Mechanisms and impact of altered tumour mechanics
H Mohammadi, E Sahai - Nature cell biology, 2018 - nature.com
The physical characteristics of tumours are intricately linked to the tumour phenotype and
difficulties during treatment. Many factors contribute to the increased stiffness of tumours; …
difficulties during treatment. Many factors contribute to the increased stiffness of tumours; …
[HTML][HTML] MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
Chemotherapy is the preferred treatment for advanced stage gastric cancer (GC) patients
and chemotherapy resistance is the major obstacle to effective cancer therapy. Increasing …
and chemotherapy resistance is the major obstacle to effective cancer therapy. Increasing …
[PDF][PDF] Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR‐338‐3p/PKM2 axis under hypoxic stress
Q Li, X Pan, D Zhu, Z Deng, R Jiang, X Wang - Hepatology, 2019 - Wiley Online Library
Glucose metabolism reprogramming, which is a well‐established characteristic of multiple
cancers, demands a higher rate of glycolysis to meet the increasing demands for …
cancers, demands a higher rate of glycolysis to meet the increasing demands for …
[HTML][HTML] Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
S Herbertz, JS Sawyer, AJ Stauber… - Drug design …, 2015 - Taylor & Francis
Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological
processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks …
processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks …
[HTML][HTML] Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
A majority of cancers fail to respond to immunotherapy with antibodies targeting immune
checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 …
checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 …
[HTML][HTML] Classification of current anticancer immunotherapies
During the past decades, anticancer immunotherapy has evolved from a promising
therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now …
therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now …
[HTML][HTML] Emerging functions of regulatory T cells in tissue homeostasis
A Sharma, D Rudra - Frontiers in immunology, 2018 - frontiersin.org
CD4+ Foxp3+ regulatory T-cells (Tregs) are a unique subset of helper T-cells, which
regulate immune response and establish peripheral tolerance. Tregs not only maintain the …
regulate immune response and establish peripheral tolerance. Tregs not only maintain the …
A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations
Purpose: Throughout their development, tumors are challenged by the immune system, and
they acquire features to evade its surveillance. A systematic view of these traits, which shed …
they acquire features to evade its surveillance. A systematic view of these traits, which shed …
Tissue-resident memory T cells at the center of immunity to solid tumors
D Amsen, KPJM van Gisbergen, P Hombrink… - Nature …, 2018 - nature.com
Immune responses in tissues are constrained by the physiological properties of the tissue
involved. Tissue-resident memory T cells (TRM cells) are a recently discovered lineage of T …
involved. Tissue-resident memory T cells (TRM cells) are a recently discovered lineage of T …
[HTML][HTML] Revisiting the hallmarks of cancer
The hallmarks of cancer described by Hanahan and Weinberg have proved seminal in our
understanding of cancer's common traits and in rational drug design. Not free of critique and …
understanding of cancer's common traits and in rational drug design. Not free of critique and …